Pharmacology News and Research

Latest Pharmacology News and Research

Genetic discoveries show promise for developing new treatment targets for schizophrenia

In recent years, genome-wide association studies (GWAS) have identified many different genetic variants associated with schizophrenia.

22 May 2020

Novel molecular structures developed for desired transcriptional response

Insilico Medicine announces the publication of a new research paper titled "Molecular Generation for Desired Transcriptome Changes With Adversarial Autoencoders" in Frontiers in Pharmacology

20 May 2020

Chemicals found in consumer products could contribute to onset of lipid-related diseases

Chemical compounds found in many consumer products could be major contributors to the onset of lipid-related diseases, such as obesity, in humans, according to a Baylor University study.

19 May 2020

Phase IIB clinical trial initiated for treating hepatitis B-associated liver cancer

The first patients have been dosed in a multi-regional Phase IIB randomized, placebo-controlled clinical trial for the treatment of hepatitis B-associated liver cancer.

19 May 2020

A new tool to study and map the intricacies of intercellular signaling

How do cells move? Why do they move? Why do some cancer cells move slowly while others move quickly, causing a cancerous tumor to metastasize and become much more difficult to treat effectively?

18 May 2020

Specific immune cells induced by vaccination are early indicators of vaccine efficacy

Ludwig-Maximilians-Universität in Munich researchers have shown that a specific class of immune cells in the blood induced by vaccination is an earlier indicator of vaccine efficacy than conventional tests for neutralizing antibodies.

15 May 2020

Precision medicine can determine the best drug treatment for severe heart disease

Is personalized medicine cost-effective? University of Alabama at Birmingham researcher Nita Limdi, Pharm.D., Ph.D., and colleagues across the United States have answered that question for one medical treatment.

15 May 2020

Using supercomputers to screen drugs for deadly heart arrhythmias

Death from sudden cardiac arrest makes headlines when it strikes athletes. But it also causes the most deaths by natural causes in the U.S. estimated at 325,000 per year.

14 May 2020

I-ACT for Children's COVID-19 Emergency Access Program launched to accelerate pediatric trials

As the number of children with severe COVID-19 illness grows, there is increasing urgency to ensure that potential treatments and vaccines are tested for safety and efficacy in children.

14 May 2020

Study explores whether senicapoc drug can mitigate lung damage in COVID-19 patients

Scientists around the globe are working to identify approved and investigational drugs that can be repurposed to treat COVID-19.

13 May 2020

Finding new therapeutic strategies for aggressive T-cell acute lymphoblastic leukemia

Aiming to identify new therapeutic strategies for the aggressive hematological disease T-cell acute lymphoblastic leukemia (T-ALL), Rutgers Cancer Institute of New Jersey resident researcher Daniel Herranz Benito, PhD, along with collaborators from Princeton University, found a new drug that has therapeutic effect against T-ALL by inhibiting SHMT and is complementary to standard-of-care treatment.

12 May 2020

New technology enables simultaneous imaging of multiple proteins

Degenerative diseases such as Alzheimer's often involve complex interactions between multiple proteins and other biomolecules.

12 May 2020

Microbiome controls the fitness of our immune system

Working alongside colleagues in Mainz, Bern, Hannover and Bonn, researchers from Charité - Universitätsmedizin Berlin, the Berlin Institute of Health and the German Rheumatism Research Center Berlin were able to show how the microbiome helps to render the immune system capable of responding to pathogens.

11 May 2020

AI VIVO seeks pharma, biotech collaboration partners to advance drug candidates for COVID-19

AI VIVO has announced that it is seeking pharma and biotech collaboration partners to progress therapeutic candidates for COVID-19.

11 May 2020

Repurposing existing drugs is a more rapid alternative than developing COVID-19 vaccine

Repurposing existing medicines focused on known drug targets is likely to offer a more rapid hope of tackling COVID-19 than developing and manufacturing a vaccine, argue an international team of scientists in the British Journal of Pharmacology today.

8 May 2020

A comprehensive review on therapeutic properties of plants

Nature is an amazing source for food, shelter, clothing and medicine. An impressive number of modern drugs are isolated from many sources such as plants, animals and microbes.

8 May 2020

Study provides indications and techniques of lower extremity revascularization

Lower extremity artery disease is a leading cause of morbidity and mortality worldwide, affecting hundreds of millions of people.

7 May 2020

Antibiotic combined with measurement technology may save time and money in developing new active ingredients

A minimal – and therefore innocuous – dose of an antibiotic coupled with highly sensitive measurement technology could save time and money in the development of new active ingredients.

7 May 2020

ISH releases 2020 Global Hypertension Practice Guidelines

High blood pressure (hypertension) is the leading cause of death in the world affecting more than 1.4 billion people and accounting for more than 28,000 deaths each day.

6 May 2020

New therapeutic possibilities for treating intellectual disability in Down syndrome

A team of researchers has studied the neural basis of intellectual disability in mice with Down syndrome and has discovered that the neural networks of brain circuits relevant to memory and learning are over-activated and that the connectivity of these circuits is poor.

5 May 2020

Pharmacology News and Research

Latest Pharmacology News and Research

Genetic discoveries show promise for developing new treatment targets for schizophrenia

Novel molecular structures developed for desired transcriptional response

Chemicals found in consumer products could contribute to onset of lipid-related diseases

Phase IIB clinical trial initiated for treating hepatitis B-associated liver cancer

A new tool to study and map the intricacies of intercellular signaling

Specific immune cells induced by vaccination are early indicators of vaccine efficacy

Precision medicine can determine the best drug treatment for severe heart disease

Using supercomputers to screen drugs for deadly heart arrhythmias

I-ACT for Children's COVID-19 Emergency Access Program launched to accelerate pediatric trials

Study explores whether senicapoc drug can mitigate lung damage in COVID-19 patients

Finding new therapeutic strategies for aggressive T-cell acute lymphoblastic leukemia

New technology enables simultaneous imaging of multiple proteins

Microbiome controls the fitness of our immune system

AI VIVO seeks pharma, biotech collaboration partners to advance drug candidates for COVID-19

Repurposing existing drugs is a more rapid alternative than developing COVID-19 vaccine

A comprehensive review on therapeutic properties of plants

Study provides indications and techniques of lower extremity revascularization

Antibiotic combined with measurement technology may save time and money in developing new active ingredients

ISH releases 2020 Global Hypertension Practice Guidelines

New therapeutic possibilities for treating intellectual disability in Down syndrome

Pittcon Highlights: Pharmaceutical & Biologic eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Pharmacology News and Research

Latest Pharmacology News and Research

Pittcon Highlights: Pharmaceutical & Biologic eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in